Grants and Contributions:
Title:
Therapeutic Antibody Lead Selection and Optimization for Oncology Targets
Agreement Number:
993571
Agreement Value:
$626,080.00
Agreement Date:
Aug 1, 2022 - May 31, 2024
Description:
Somru Bioscience Inc. has developed a library of antibodies against oncology targets. In this project we intend to sift through thousands of hits to generate leads with therapeutic potential.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1E 0B7
Reference Number:
172-2022-2023-Q2-993571
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
806733887
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days. The total amended value is 69,376 dollars.
Amendment Date
Mar 14, 2024
Recipient's Legal Name:
Somru BioScience Inc.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: